Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The GyneFix implant systems for interval, postabortal and postpartum contraception: a significant advance in long-term reversible contraception. International Study Group on Intrauterine Drug Delivery.
Van Kets H, Van der Pas H, Thiery M, Wildemeersch D, Vrijens M, Van Trappen Y, Temmerman M, DePypere H, Delbarge W, Dhont M, Defoort P, Schacht EH, Bàtàr I, Barri P, Martinez F, Iglesias Cortit LH, Creatsas G, Shangchun W, Xiaoming C, Zuan-chong F, Yu-ming W, Andrade A, Reinprayoon D, Pizarro E. Van Kets H, et al. Among authors: barri p. Eur J Contracept Reprod Health Care. 1997 Mar;2(1):1-13. doi: 10.1080/13625189709049929. Eur J Contracept Reprod Health Care. 1997. PMID: 9678104 Review.
IUD expulsion solved with implant technology.
Van Kets H, Wildemeersch D, van der Pas H, Vrijens M, Van Trappen Y, Delbarge W, Temmerman M, Batar I, Barri P, Martinez F, et al. Van Kets H, et al. Among authors: barri p. Contraception. 1995 Feb;51(2):87-92. doi: 10.1016/0010-7824(94)00013-m. Contraception. 1995. PMID: 7750295
Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection.
Arce JC, Andersen AN, Fernández-Sánchez M, Visnova H, Bosch E, García-Velasco JA, Barri P, de Sutter P, Klein BM, Fauser BC. Arce JC, et al. Among authors: barri p. Fertil Steril. 2014 Dec;102(6):1633-40.e5. doi: 10.1016/j.fertnstert.2014.08.013. Epub 2014 Sep 23. Fertil Steril. 2014. PMID: 25256937 Free article. Clinical Trial.
Follicular and endocrine dose responses according to anti-Müllerian hormone levels in IVF patients treated with a novel human recombinant FSH (FE 999049).
Bosch E, Nyboe Andersen A, Barri P, García-Velasco JA, de Sutter P, Fernández-Sánchez M, Visnova H, Klein BM, Mannaerts B, Arce JC. Bosch E, et al. Among authors: barri p. Clin Endocrinol (Oxf). 2015 Dec;83(6):902-12. doi: 10.1111/cen.12864. Epub 2015 Sep 3. Clin Endocrinol (Oxf). 2015. PMID: 26202150 Clinical Trial.
A randomized, controlled, first-in-patient trial of choriogonadotropin beta added to follitropin delta in women undergoing ovarian stimulation in a long GnRH agonist protocol.
Fernández Sánchez M, Višnová H, Larsson P, Yding Andersen C, Filicori M, Blockeel C, Pinborg A, Khalaf Y, Mannaerts B; Rainbow Study Group. Fernández Sánchez M, et al. Hum Reprod. 2022 May 30;37(6):1161-1174. doi: 10.1093/humrep/deac061. Hum Reprod. 2022. PMID: 35451013 Free PMC article.
A multi-centre phase 3 study comparing efficacy and safety of Bemfola(®) versus Gonal-f(®) in women undergoing ovarian stimulation for IVF.
Rettenbacher M, Andersen AN, Garcia-Velasco JA, Sator M, Barri P, Lindenberg S, van der Ven K, Khalaf Y, Bentin-Ley U, Obruca A, Tews G, Schenk M, Strowitzki T, Narvekar N, Sator K, Imthurn B. Rettenbacher M, et al. Among authors: barri p. Reprod Biomed Online. 2015 May;30(5):504-13. doi: 10.1016/j.rbmo.2015.01.005. Epub 2015 Jan 27. Reprod Biomed Online. 2015. PMID: 25735918 Free article. Clinical Trial.
154 results